Inflammation-relevant microbiome signature of the stroke brain, gut, spleen, and thymus and the impact of exercise. Issue 12 (December 2021)

• Record Type: Journal Article
• Authors: Kingsbury, Chase; Shear, Alex; Heyck, Matt; Sadanandan, Nadia; Zhang, Henry; Gonzales-Portillo, Bella; Cozene, Blaise; Sheyner, Michael; Navarro-Torres, Lisset; García-Sánchez, Julián; Lee, Jea-Young; Borlongan, Cesario V
• Is Part Of: Journal of cerebral blood flow & metabolism. Volume 41:Issue 12(2021)
• Page Start: 3200
• Page End: 3212
• Publication Date: 2021-12
• Subjects: Cerebral ischemia -- inflammation -- exercise -- microbiota -- neuroprotection; Cerebral circulation -- Periodicals; Brain -- Metabolism -- Periodicals; Brain -- Blood-vessels -- Periodicals; Cerebrovascular disease -- Periodicals; 612.824
• DOI: 10.1177/0271678X211039598
• Languages: English
• ISSNs: 0271-678X

Abstract

Stroke remains a significant unmet need in the clinic with few therapeutic options. We, and others, have implicated the role of inflammatory microbiota in stroke secondary cell death. Elucidating this inflammation microbiome as a biomarker may improve stroke diagnosis and treatment. Here, adult Sprague-Dawley rats performed 30 minutes of exercise on a motorized treadmill for 3 consecutive days prior to transient middle cerebral artery occlusion (MCAO). Stroke animals that underwent exercise showed 1) robust behavioral improvements, 2) significantly smaller infarct sizes and increased peri-infarct cell survival and 3) decreasing trends of inflammatory microbiota BAC303, EREC482, and LAB158 coupled with significantly reduced levels of inflammatory markers ionized calcium binding adaptor molecule 1, tumor necrosis factor alpha, and mouse monoclonal MHC Class II RT1B in the brain, gut, spleen, and thymus compared to non-exercised stroke rats. These results suggest that a specific set of inflammatory microbiota exists in central and peripheral organs and can serve as a disease biomarker and a therapeutic target for stroke.